These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18363193)

  • 1. [The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - contra].
    Köhler D
    Dtsch Med Wochenschr; 2008 Apr; 133(14):721. PubMed ID: 18363193
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - pro].
    Ghofrani HA
    Dtsch Med Wochenschr; 2008 Apr; 133(14):720. PubMed ID: 18363192
    [No Abstract]   [Full Text] [Related]  

  • 3. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Kuschner WG
    N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528810
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
    Jue VI
    Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternatives to nitric oxide.
    Lowson SM
    Br Med Bull; 2004; 70():119-31. PubMed ID: 15531733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension, pulmonary blood vessels and vasoactive drugs.
    Wanstall JC
    Proc West Pharmacol Soc; 1997; 40():137-40. PubMed ID: 9436235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative administration of PDE-5 Inhibitors.
    Edwards AF; Roy RC
    J Clin Anesth; 2009 Mar; 21(2):149; author reply 149-50. PubMed ID: 19329023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil 20 mg. Pulmonary arterial hypertension: for oral treatment, no better than bosentan.
    Prescrire Int; 2006 Dec; 15(86):221. PubMed ID: 17167928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension].
    Ghofrani HA; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Dtsch Med Wochenschr; 2006 Apr; 131(16):871-4. PubMed ID: 16625479
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of pulmonary arterial hypertension].
    Pulido Zamudio T
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-198-201. PubMed ID: 18938726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment of pulmonary hypertension in patients with congenital heart disease].
    Miera O; Farahwaschy B; Schulze-Neick I; Berger F
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S209-11. PubMed ID: 18814099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes.
    Hey JC; Scharf SM
    Isr Med Assoc J; 2003 Apr; 5(4):298-303. PubMed ID: 14509142
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary arterial hypertension in a Kartagener syndrome patient: treatment with beraprost sodium.
    Shen YC; Wen FQ; Yi Q
    Int J Cardiol; 2012 Aug; 159(1):e9-10. PubMed ID: 22104985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary arterial hypertension. New therapeutic principles improve treatment of a rare condition].
    Ekmehag B
    Lakartidningen; 2009 Aug 19-25; 106(34):2057-61. PubMed ID: 19769147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Right heart failure in the ICU. The primary goal of treatment is to reduce right ventricular afterload].
    Stiefelhagen P
    Med Monatsschr Pharm; 2012 May; 35(5):183-5. PubMed ID: 22624352
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treprostinil (Remodulin) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2002 Sep; 44(1139):80-2. PubMed ID: 12237619
    [No Abstract]   [Full Text] [Related]  

  • 19. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN) is in its infancy.
    Kissoon N
    J Crit Care; 2006 Jun; 21(2):223. PubMed ID: 16769472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.